Market revenue in 2024 | USD 33.3 million |
Market revenue in 2030 | USD 57.6 million |
Growth rate | 9.5% (CAGR from 2025 to 2030) |
Largest segment | Sequence analysis platforms |
Fastest growing segment | Sequence Analysis Platforms |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management |
Key market players worldwide | Certara Inc Ordinary Shares, Boehringer Ingelheim, Infosys Ltd ADR, Charles River Laboratories International Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Oracle Corp, Accenture PLC Class A, Agilent Technologies Inc, Illumina Inc, Eurofins Scientific SE, Jubilant Biosys, Selvita, ChemAxon, Albany Molecular Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery informatics market will help companies and investors design strategic landscapes.
Sequence analysis platforms was the largest segment with a revenue share of 41.14% in 2024. Horizon Databook has segmented the South Africa drug discovery informatics market based on sequence analysis platforms, molecular modelling, docking, clinical trial data management covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of new drug discovery and development centre such as South African Medical Research Council (SAMRC) that promises to bridge the gap between basic sciences and drug development is expected to register considerable growth over the forecast period.
Moreover, OnQ research is a South African Research Organisation for clinical research outsourcing which is anticipated to impact informatics demand positively over the forecast period. In order to speed up the drug registration process, a new drug regulatory agency named South African Health Products Regulatory Authority (SAHPRA) was established.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa drug discovery informatics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa drug discovery informatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account